Profiles

Keywords
Last Name
Institution

Ross Abrams

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentRadiation Oncology
AddressChicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7202587300


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jones WE, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Small W, Herman JM. ACR Appropriateness Criteria® Resectable Pancreatic Cancer. Am J Clin Oncol. 2017 Apr; 40(2):109-117. PMID: 28230650.
      View in: PubMed
    2. Fokas E, Spezi E, Patel N, Hurt C, Nixon L, Chu KY, Staffurth J, Abrams R, Mukherjee S. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial. Radiother Oncol. 2016 Aug; 120(2):212-6. PMID: 27497804; PMCID: PMC5013754.
    3. ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer. Oncology (Williston Park). 2016 Jul; 30(7):619-24, 627, 632. PMID: 27422109.
      View in: PubMed
    4. Blumenfeld P, Sen N, Abrams R, Wang D. Advances in Radiation Therapy for Primary and Metastatic Adult Soft Tissue Sarcomas. Curr Oncol Rep. 2016 Jun; 18(6):36. PMID: 27113370.
      View in: PubMed
    5. Kouri BE, Abrams RA, Al-Refaie WB, Azad N, Farrell J, Gaba RC, Gervais DA, Gipson MG, Kolbeck KJ, Marshalleck FE, Pinchot JW, Small W, Ray CE, Hohenwalter EJ. ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy. J Am Coll Radiol. 2016 Mar; 13(3):265-73. PMID: 26944037.
      View in: PubMed
    6. Li D, Moughan J, Crane C, Hoffman JP, Regine WF, Abrams RA, Safran H, Liu C, Chang P, Freedman GM, Winter KA, Guha C, Abbruzzese JL. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):554-60. PMID: 26725729; PMCID: PMC4876948.
    7. Fokas E, Clifford C, Spezi E, Joseph G, Branagan J, Hurt C, Nixon L, Abrams R, Staffurth J, Mukherjee S. Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial. Radiother Oncol. 2015 Dec; 117(3):432-7. PMID: 26328939.
      View in: PubMed
    8. Hurt CN, Mukherjee S, Bridgewater J, Falk S, Crosby T, McDonald A, Joseph G, Staffurth J, Abrams RA, Blazeby JM, Bridges S, Dutton P, Griffiths G, Maughan T, Johnson C. Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93(4):810-8. PMID: 26530749; PMCID: PMC4627359.
    9. Brown PD, Anderson SK, Carrero XW, O'Neill BP, Giannini C, Galanis E, Shah SA, Abrams RA, Curran WJ, Buckner JC, Shaw EG. Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance). Neurooncol Pract. 2015 Dec; 2(4):199-204. PMID: 26640699.
      View in: PubMed
    10. Ben-Josef E, George A, Regine WF, Abrams R, Morgan M, Thomas D, Schaefer PL, DiPetrillo TA, Fromm M, Small W, Narayan S, Winter K, Griffith KA, Guha C, Williams TM. Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res. 2015 Dec 15; 21(24):5612-8. PMID: 26240274.
      View in: PubMed
    11. Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O'Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):602-12. PMID: 26068493.
      View in: PubMed
    12. Baldini EH, Bosch W, Kane JM, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D. Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists. Ann Surg Oncol. 2015 Sep; 22(9):2846-52. PMID: 26018727; PMCID: PMC4684182.
    13. Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RLM, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1053-1059. PMID: 26194680; PMCID: PMC4684186.
    14. Katz DA, Abrams RA, Sclamberg JS, Usha L. Radiosensitizing effect of anti-HER2/neu agents: Report of 2 cases and review of the literature. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):e61-5. PMID: 25413407.
      View in: PubMed
    15. Sen N, Falk S, Abrams RA. Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer. Clin Oncol (R Coll Radiol). 2014 Sep; 26(9):551-9. PMID: 25024090.
      View in: PubMed
    16. Wang D, Abrams RA. Radiotherapy for soft tissue sarcoma: 50 years of change and improvement. Am Soc Clin Oncol Educ Book. 2014; 244-51. PMID: 24857082.
      View in: PubMed
    17. Wang-Gillam A, Abrams RA, Posner MC, Pisters PW, Picozzi VJ. Supportive care considerations during concurrent chemoradiotherapy for pancreatic adenocarcinoma: lessons learned from clinical experience. Am J Clin Oncol. 2013 Dec; 36(6):637-43. PMID: 22237148.
      View in: PubMed
    18. Mukherjee S, Hurt CN, Bridgewater J, Falk S, Cummins S, Wasan H, Crosby T, Jephcott C, Roy R, Radhakrishna G, McDonald A, Ray R, Joseph G, Staffurth J, Abrams RA, Griffiths G, Maughan T. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol. 2013 Apr; 14(4):317-26. PMID: 23474363; PMCID: PMC3620899.
    19. Bahig H, Roberge D, Bosch W, Levin W, Petersen I, Haddock M, Freeman C, Delaney TF, Abrams RA, Indelicato DJ, Baldini EH, Hitchcock Y, Kirsch DG, Kozak KR, Wolfson A, Wang D. Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):298-303. PMID: 23474110; PMCID: PMC3646910.
    20. Vainshtein JM, Schipper M, Zalupski MM, Lawrence TS, Abrams R, Francis IR, Khan G, Leslie W, Ben-Josef E. Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):96-101. PMID: 23265573; PMCID: PMC3646633.
    21. Abrams RA. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma. Cancer J. 2012 Nov-Dec; 18(6):624-32. PMID: 23187851.
      View in: PubMed
    22. Huguet F, Goodman KA, Azria D, Racadot S, Abrams RA. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1355-64. PMID: 22768988.
      View in: PubMed
    23. Garg S, Abrams RA, Leslie WT. Successful treatment of anal carcinoma with Paclitaxel, Cisplatin, and radiotherapy in a patient who developed a coronary syndrome from 5-fu. Gastrointest Cancer Res. 2012 Jul; 5(4):135-6. PMID: 23077688; PMCID: PMC3433263.
    24. Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, Macdonald J, Willett CG. Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 =90 U/mL and comparison to the CONKO-001 trial. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):e291-7. PMID: 22682806.
      View in: PubMed
    25. Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM, Sonnenday C, Abrams R, Leslie W, Khan G, Zalupski MM. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1166-71. PMID: 22543215; PMCID: PMC3421048.
    26. Goodman KA, Regine WF, Dawson LA, Ben-Josef E, Haustermans K, Bosch WR, Turian J, Abrams RA. Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):901-8. PMID: 22483737.
      View in: PubMed
    27. Abrams RA. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful? Expert Rev Gastroenterol Hepatol. 2012 Apr; 6(2):149-61. PMID: 22375521.
      View in: PubMed
    28. Yao R, Bernard D, Turian J, Abrams RA, Sensakovic W, Fung HC, Chu JC. A simplified technique for delivering total body irradiation (TBI) with improved dose homogeneity. Med Phys. 2012 Apr; 39(4):2239-48. PMID: 22482645.
      View in: PubMed
    29. Strauss JB, Wysocki RW, Shah A, Chen SS, Shah AP, Abrams RA, Cohen MS. Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery. Am J Orthop (Belle Mead NJ). 2011 Aug; 40(8):400-5. PMID: 22016869.
      View in: PubMed
    30. Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86. PMID: 21532501.
      View in: PubMed
    31. Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM, Curran WJ, Abrams RA, Schiff D, Shaw EG. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):218-24. PMID: 21549518; PMCID: PMC3151343.
    32. Regine WF, Winter KA, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Rich TA, Willett CG. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011 May; 18(5):1319-26. PMID: 21499862; PMCID: PMC3548408.
    33. Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):809-16. PMID: 21277694; PMCID: PMC3133855.
    34. Lutz E, Yeo CJ, Lillemoe KD, Biedrzycki B, Kobrin B, Herman J, Sugar E, Piantadosi S, Cameron JL, Solt S, Onners B, Tartakovsky I, Choi M, Sharma R, Illei PB, Hruban RH, Abrams RA, Le D, Jaffee E, Laheru D. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35. PMID: 21217520; PMCID: PMC3085934.
    35. Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1328-35. PMID: 20934270; PMCID: PMC3038247.
    36. Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):985-91. PMID: 20932684.
      View in: PubMed
    37. Katz MH, Merchant NB, Brower S, Branda M, Posner MC, William Traverso L, Abrams RA, Picozzi VJ, Pisters PW. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44. PMID: 20811779; PMCID: PMC3922125.
    38. Picozzi VJ, Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, Martin RC, Wilfong LS, Rothenberg ML, Posner MC, Pisters PW. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54. PMID: 20670978; PMCID: PMC3030467.
    39. Marsh JC, Gielda BT, Herskovic AM, Abrams RA. Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches. J Oncol. 2010; 2010:198208. PMID: 20671962; PMCID: PMC2910483.
    40. Liggett T, Melnikov A, Yi QL, Replogle C, Brand R, Kaul K, Talamonti M, Abrams RA, Levenson V. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer. 2010 Apr 01; 116(7):1674-80. PMID: 20143430.
      View in: PubMed
    41. Marsh JC, Herskovic AM, Gielda BT, Hughes FF, Hoeppner T, Turian J, Abrams RA. Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):504-12. PMID: 20117288.
      View in: PubMed
    42. Shah AP, Strauss JB, Abrams RA. Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer. Am J Clin Oncol. 2010 Feb; 33(1):101-6. PMID: 19636239.
      View in: PubMed
    43. Kasamon YL, Jones RJ, Brodsky RA, Fuchs EJ, Matsui W, Luznik L, Powell JD, Blackford AL, Goodrich A, Gocke CD, Abrams RA, Ambinder RF, Flinn IW. Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol. 2010 Jun; 21(6):1203-10. PMID: 19880437; PMCID: PMC2875548.
    44. Strauss JB, Gielda BT, Chen SS, Shah AP, Abrams RA, Griem KL. Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):831-5. PMID: 19800179.
      View in: PubMed
    45. Chu JCh, Gong X, Cai Y, Kirk MC, Zusag TW, Shott S, Rivard MJ, Melhus CS, Cardarelli G, Hurley A, Hepel JT, Napoli J, Stutsman S, Abrams RA. Application of holographic display in radiotherapy treatment planning II: a multi-institutional study. J Appl Clin Med Phys. 2009 May 28; 10(3):2902. PMID: 19692975.
      View in: PubMed
    46. Abrams RA, Lowy AM, O'Reilly EM, Wolff RA, Picozzi VJ, Pisters PW. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1751-6. PMID: 19390900.
      View in: PubMed
    47. Zhang Y, Chu JC, Hsi W, Khan AJ, Mehta PS, Bernard DB, Abrams RA. Evaluation of four volume-based image registration algorithms. Med Dosim. 2009; 34(4):317-22. PMID: 19854391.
      View in: PubMed
    48. Abrams RA. Cholangiocarcinoma--what level of evidence should we have? Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):1-2. PMID: 19100917.
      View in: PubMed
    49. Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):824-30. PMID: 19117696; PMCID: PMC2709288.
    50. Shah AP, Strauss JB, Leslie WT, Shah A, Mahon B, Abrams RA. Management of a patient with borderline resectable pancreatic cancer. Case report and review. Oncology (Williston Park). 2008 Nov 30; 22(13):1524-9. PMID: 19133606.
      View in: PubMed
    51. Berger AC, Garcia M, Hoffman JP, Regine WF, Abrams RA, Safran H, Konski A, Benson AB, MacDonald J, Willett CG. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22. PMID: 19029412; PMCID: PMC2645109.
    52. Farrell JJ, Elsaleh H, Garcia M, Lai R, Ammar A, Regine WF, Abrams R, Benson AB, Macdonald J, Cass CE, Dicker AP, Mackey JR. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology. 2009 Jan; 136(1):187-95. PMID: 18992248.
      View in: PubMed
    53. Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA, Yeo C, Cameron JL, Schulick RD, Abrams R. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008 Jul 20; 26(21):3503-10. PMID: 18640931; PMCID: PMC3558690.
    54. Picozzi VJ, Abrams RA, Traverso LW, O'Reilly EM, Greeno E, Martin RC, Wilfong LS, Decker PA, Pisters PW, Posner MC. ACOSOG Z05031: Report on a multicenter, phase II trial for adjuvant therapy of resected pancreatic cancer using cisplatin, 5- FU, and alpha-interferon. J Clin Oncol. 2008 May 20; 26(15_suppl):4505. PMID: 27949231.
      View in: PubMed
    55. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, Benson AB, Macdonald JS, Kudrimoti MR, Fromm ML, Haddock MG, Schaefer P, Willett CG, Rich TA. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008 Mar 05; 299(9):1019-26. PMID: 18319412.
      View in: PubMed
    56. Dickler A, Kirk MC, Seif N, Griem K, Dowlatshahi K, Francescatti D, Abrams RA. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007 Apr-Jun; 6(2):164-8. PMID: 17434111.
      View in: PubMed
    57. Swartz MJ, Hughes MA, Frassica DA, Herman J, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007 Mar; 142(3):285-8. PMID: 17372054.
      View in: PubMed
    58. Hughes MA, Frassica DA, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):178-82. PMID: 17276614.
      View in: PubMed
    59. Abrams RA. Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal". Drugs. 2007; 67(17):2481-5; discussion 2491-3. PMID: 18034585.
      View in: PubMed
    60. Regine WF, Abrams RA. Adjuvant therapy for pancreatic cancer: current status, future directions. Semin Oncol. 2006 Dec; 33(6 Suppl 11):S10-3. PMID: 17178279.
      View in: PubMed
    61. Khan AJ, Mehta PS, Zusag TW, Bonomi PD, Penfield Faber L, Shott S, Abrams RA. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol. 2006 Nov; 81(2):163-7. PMID: 17050016.
      View in: PubMed
    62. Abrams RA. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S30-2. PMID: 16399427.
      View in: PubMed
    63. Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, Abrams RA, Laheru D, Hruban RH, Yeo CJ. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005 Dec; 9(9):1191-204; discussion 1204-6. PMID: 16332474.
      View in: PubMed
    64. Dickler A, Abrams RA. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings. Semin Radiat Oncol. 2005 Oct; 15(4):235-44. PMID: 16183477.
      View in: PubMed
    65. Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8. PMID: 15939930.
      View in: PubMed
    66. Zhang Y, Hsi WC, Chu JC, Bernard DB, Abrams RA. A feasibility study of Dynamic Phantom scanner for quality assurance of photon beam profiles at various gantry angles. J Appl Clin Med Phys. 2005; 6(2):50-61. PMID: 15940212.
      View in: PubMed
    67. Koshy MC, Landry JC, Cavanaugh SX, Fuller CD, Willett CG, Abrams RA, Hoffman JP, Thomas CR. A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):965-6. PMID: 15752874.
      View in: PubMed
    68. Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith BD, Flinn IW. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biol Blood Marrow Transplant. 2005 Feb; 11(2):93-100. PMID: 15682069.
      View in: PubMed
    69. Kasamon YL, Jones RJ, Diehl LF, Nayer H, Borowitz MJ, Garrett-Mayer E, Ambinder RF, Abrams RA, Zhang Z, Flinn IW. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant. 2005 Jan; 11(1):39-46. PMID: 15625543.
      View in: PubMed
    70. Abrams RA, Yeo CJ. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am. 2004 Oct; 13(4):621-38, ix. PMID: 15350938.
      View in: PubMed
    71. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG. Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):117-25. PMID: 15093907.
      View in: PubMed
    72. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Abrams RA, Curran WJ, Shaw EG. Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1153-60. PMID: 15001258.
      View in: PubMed
    73. Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W, Safran H, Wanebo HJ. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb; 27(1):51-6. PMID: 14758134.
      View in: PubMed
    74. Bettegowda C, Dang LH, Abrams R, Huso DL, Dillehay L, Cheong I, Agrawal N, Borzillary S, McCaffery JM, Watson EL, Lin KS, Bunz F, Baidoo K, Pomper MG, Kinzler KW, Vogelstein B, Zhou S. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A. 2003 Dec 09; 100(25):15083-8. PMID: 14657371; PMCID: PMC299912.
    75. Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol. 2003 Dec 15; 21(24):4553-9. PMID: 14597743.
      View in: PubMed
    76. Song DY, Jones RJ, Welsh JS, Haulk TL, Korman LT, Noga S, Goodman S, Herman M, Mann R, Marcellus D, Vogelsang G, Ambinder RF, Abrams RA. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71. PMID: 12909229.
      View in: PubMed
    77. Chakravarti A, Heydon K, Wu CL, Hammond E, Pollack A, Roach M, Wolkov H, Okunieff P, Cox J, Fontanesi J, Abrams R, Pilepich M, Shipley W. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. J Clin Oncol. 2003 Sep 01; 21(17):3328-34. PMID: 12947069.
      View in: PubMed
    78. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol. 2003 Jul 01; 21(13):2519-24. PMID: 12829670.
      View in: PubMed
    79. Pollack A, Grignon DJ, Heydon KH, Hammond EH, Lawton CA, Mesic JB, Fu KK, Porter AT, Abrams RA, Shipley WU. Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 2003 Apr 01; 21(7):1238-48. PMID: 12663710.
      View in: PubMed
    80. Abrams RA. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):3-9. PMID: 12826245.
      View in: PubMed
    81. Willett CG, Safran H, Abrams RA, Regine WF, Rich TA. Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):31-7. PMID: 12826249.
      View in: PubMed
    82. Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA, Coleman J, Sauter PK, Abrams RA, Hruban RH, Yeo CJ. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg. 2003 Jan; 7(1):1-9; discussion 9-11. PMID: 12559179.
      View in: PubMed
    83. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002 Sep; 236(3):355-66; discussion 366-8. PMID: 12192322; PMCID: PMC1422589.
    84. Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto MI, Abrams RA, Laheru D, Jaffee EM, Hidalgo M, Yeo CJ. Pancreatic cancer. Curr Probl Cancer. 2002 Jul-Aug; 26(4):176-275. PMID: 12399802.
      View in: PubMed
    85. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002 May 01; 20(9):2267-76. PMID: 11980997.
      View in: PubMed
    86. Abrams RA. Communication. Lancet. 2002 Apr 06; 359(9313):1245. PMID: 11955560.
      View in: PubMed
    87. Akpek G, Ambinder RF, Piantadosi S, Abrams RA, Brodsky RA, Vogelsang GB, Zahurak ML, Fuller D, Miller CB, Noga SJ, Fuchs E, Flinn IW, O'Donnell P, Seifter EJ, Mann RB, Jones RJ. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol. 2001 Dec 01; 19(23):4314-21. PMID: 11731514.
      View in: PubMed
    88. Tascilar M, Skinner HG, Rosty C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE, Yeo CJ, Hruban RH, Goggins M. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2001 Dec; 7(12):4115-21. PMID: 11751510.
      View in: PubMed
    89. Abrams RA, Lillemoe KD, Piantadosi S. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet. 2001 Nov 10; 358(9293):1565-6. PMID: 11716876.
      View in: PubMed
    90. Song DY, Lawrie WT, Abrams RA, Kafonek DR, Bayless TM, Welsh JS, DeWeese TL. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):455-9. PMID: 11567821.
      View in: PubMed
    91. Lawrence BM, Myerson J, Oonk HM, Abrams RA. The effects of eye and limb movements on working memory. Memory. 2001 Jul-Nov; 9(4-6):433-44. PMID: 11594362.
      View in: PubMed
    92. Willett C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkey B, Benetz M, Crane C, Gaspar L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Mitchell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):19-27. PMID: 11641011.
      View in: PubMed
    93. Abrams RA. Adjuvant therapy for pancreatic adenocarcinoma. J Gastrointest Surg. 2001 Jan-Feb; 5(1):6-7. PMID: 11370618.
      View in: PubMed
    94. Jaffee EM, Hruban RH, Biedrzycki B, Laheru D, Schepers K, Sauter PR, Goemann M, Coleman J, Grochow L, Donehower RC, Lillemoe KD, O'Reilly S, Abrams RA, Pardoll DM, Cameron JL, Yeo CJ. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001 Jan 01; 19(1):145-56. PMID: 11134207.
      View in: PubMed
    95. Berdeja JG, Jones RJ, Zahurak ML, Piantadosi S, Abrams RA, Borowitz MJ, Vogelsang GB, Noga SJ, Ambinder RF, Flinn IW. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. Biol Blood Marrow Transplant. 2001; 7(10):561-7. PMID: 11760088.
      View in: PubMed
    96. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000 Nov-Dec; 4(6):567-79. PMID: 11307091.
      View in: PubMed
    97. Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):1089-96. PMID: 11072167.
      View in: PubMed
    98. Abrams RA. Is there a role for radiotherapy in the management of upper gastrointestinal malignancies? Surg Oncol Clin N Am. 2000 Jul; 9(3):525-38, ix. PMID: 10853140.
      View in: PubMed
    99. Abrams RA, Law MB. Object-based visual attention with endogenous orienting. Percept Psychophys. 2000 May; 62(4):818-33. PMID: 10883587.
      View in: PubMed
    100. Koniaris LG, Lillemoe KD, Yeo CJ, Abrams RA, Colemann J, Nakeeb A, Pitt H, Cameron JL. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000 Mar; 190(3):319-30. PMID: 10703858.
      View in: PubMed
    101. Horton KM, Abrams RA, Fishman EK. Spiral CT of colon cancer: imaging features and role in management. Radiographics. 2000 Mar-Apr; 20(2):419-30. PMID: 10715340.
      View in: PubMed
    102. Flinn IW, O'Donnell PV, Goodrich A, Vogelsang G, Abrams R, Noga S, Marcellus D, Borowitz M, Jones R, Ambinder RF. Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Biol Blood Marrow Transplant. 2000; 6(6):628-32. PMID: 11128813.
      View in: PubMed
    103. Vogelsang G, Bitton R, Piantadosi S, Altomonte V, Horn T, Jones R, Miller C, Marcellus D, Abrams R, Hess A. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial. Bone Marrow Transplant. 1999 Sep; 24(6):637-40. PMID: 10490729.
      View in: PubMed
    104. Abrams RA, Grochow LB, Chakravarthy A, Sohn TA, Zahurak ML, Haulk TL, Ord S, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL, Yeo CJ. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1039-46. PMID: 10421536.
      View in: PubMed
    105. Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999 Feb; 22(1):22-8. PMID: 10025374.
      View in: PubMed
    106. Skolasky RL, Dal Pan GJ, Olivi A, Lenz FA, Abrams RA, McArthur JC. HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci. 1999 Feb 01; 163(1):32-8. PMID: 10223407.
      View in: PubMed
    107. O'Donnell PV, Jones RJ, Vogelsang GB, Seber A, Ambinder RF, Flinn I, Miller C, Marcellus DC, Griffin C, Abrams R, Braine HG, Grever M, Hess AD, Piantadosi S, Noga SJ. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. Bone Marrow Transplant. 1998 Nov; 22(10):947-55. PMID: 9849691.
      View in: PubMed
    108. Jaffee EM, Abrams R, Cameron J, Donehower R, Duerr M, Gossett J, Greten TF, Grochow L, Hruban R, Kern S, Lillemoe KD, O'Reilly S, Pardoll D, Pitt HA, Sauter P, Weber C, Yeo C. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum Gene Ther. 1998 Sep 01; 9(13):1951-71. PMID: 9741433.
      View in: PubMed
    109. Regine WF, Abrams RA. Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys. 1998 Aug 01; 42(1):59-63. PMID: 9747820.
      View in: PubMed
    110. Sohn TA, Yeo CJ, Cameron JL, Lillemoe KD, Talamini MA, Hruban RH, Sauter PK, Coleman J, Ord SE, Grochow LB, Abrams RA, Pitt HA. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998 May-Jun; 2(3):207-16. PMID: 9841976.
      View in: PubMed
    111. Abrams RA, Pajak TF, Haulk TL, Flam M, Asbell SO. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center. Cancer J Sci Am. 1998 May-Jun; 4(3):178-84. PMID: 9612600.
      View in: PubMed
    112. Abrams RA, Oonk HM, Pratt J. Fixation point offsets facilitate endogenous saccades. Percept Psychophys. 1998 Feb; 60(2):201-8. PMID: 9529904.
      View in: PubMed
    113. Abrams RA, Cardinale RM, Enger C, Haulk TL, Hurwitz H, Osterman F, Sitzmann JV. Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1077-85. PMID: 9392547.
      View in: PubMed
    114. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep; 226(3):248-57; discussion 257-60. PMID: 9339931; PMCID: PMC1191017.
    115. Abrams RA, Liu PJ, Ambinder RF, Haulk TL, Korman LT, Herman MG, Jones RJ. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation. Radiology. 1997 Jun; 203(3):865-70. PMID: 9169718.
      View in: PubMed
    116. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May; 225(5):621-33; discussion 633-6. PMID: 9193189; PMCID: PMC1190807.
    117. Forastiere AA, Heitmiller RF, Lee DJ, Zahurak M, Abrams R, Kleinberg L, Watkins S, Yeo CJ, Lillemoe KD, Sitzmann JV, Sharfman W. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997 May-Jun; 3(3):144-52. PMID: 9161779.
      View in: PubMed
    118. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, Hruban RH, Abrams RA, Pitt HA. Pancreaticoduodenectomy and palliation in pancreatic carcinoma. Gastroenterology. 1997 Mar; 112(3):1046-8. PMID: 9041274.
      View in: PubMed
    119. Bluemke DA, Abrams RA, Yeo CJ, Cameron JL, Fishman EK. Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure. Radiographics. 1997 Mar-Apr; 17(2):303-13. PMID: 9084073.
      View in: PubMed
    120. Grignon DJ, Caplan R, Sarkar FH, Lawton CA, Hammond EH, Pilepich MV, Forman JD, Mesic J, Fu KK, Abrams RA, Pajak TF, Shipley WU, Cox JD. p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst. 1997 Jan 15; 89(2):158-65. PMID: 8998185.
      View in: PubMed
    121. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996 Oct; 224(4):463-73; discussion 473-5. PMID: 8857851; PMCID: PMC1235406.
    122. Abrams RA. Role of radiation therapy in the management of the patient with pancreatic cancer. Oncology (Williston Park). 1996 Sep; 10(9 Suppl):13-7. PMID: 8884802.
      View in: PubMed
    123. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, Hruban RH, Abrams RA, Pitt HA. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun; 223(6):718-25; discussion 725-8. PMID: 8645045; PMCID: PMC1235219.
    124. Pratt J, Abrams RA. Practice and Component Submovements: The Roles of Programming and Feedback in Rapid Aimed Limb Movements. J Mot Behav. 1996 Jun; 28(2):149-156. PMID: 12529216.
      View in: PubMed
    125. Carducci MA, Abrams RA, Yeo CJ, Hruban RH, Zahurak ML, Cameron JL, Grochow LB. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):143-50. PMID: 8641911.
      View in: PubMed
    126. Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom J. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol. 1996 Feb; 14(2):556-64. PMID: 8636771.
      View in: PubMed
    127. Abrams RA, Grochow LB. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head. Surg Clin North Am. 1995 Oct; 75(5):925-38. PMID: 7660255.
      View in: PubMed
    128. Lee DJ, Cosmatos D, Marcial VA, Fu KK, Rotman M, Cooper JS, Ortiz HG, Beitler JJ, Abrams RA, Curran WJ, et al. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):567-76. PMID: 7790241.
      View in: PubMed
    129. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995 Jun; 221(6):788-97; discussion 797-8. PMID: 7794082; PMCID: PMC1234714.
    130. Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P, et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 1995 Apr; 45(4):616-23. PMID: 7716842.
      View in: PubMed
    131. Law MB, Pratt J, Abrams RA. Color-based inhibition of return. Percept Psychophys. 1995 Apr; 57(3):402-8. PMID: 7770330.
      View in: PubMed
    132. Chakravarthy A, Abrams RA. Radiation therapy in the management of patients with malignant carcinoid tumors. Cancer. 1995 Mar 15; 75(6):1386-90. PMID: 7533655.
      View in: PubMed
    133. Arterbery VE, Pryor WA, Jiang L, Sehnert SS, Foster WM, Abrams RA, Williams JR, Wharam MD, Risby TH. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation: a case study. Free Radic Biol Med. 1994 Dec; 17(6):569-76. PMID: 7867973.
      View in: PubMed
    134. Raben D, Williams J, Abrams RA. The clinical use of multimodality therapy in the management of cancer. In Vivo. 1994 Nov-Dec; 8(5):635-42. PMID: 7727710.
      View in: PubMed
    135. Abrams RA. Eye-hand coordination: spatial localization after saccadic and pursuit eye movements. J Mot Behav. 1994 Sep; 26(3):215-24. PMID: 15757837.
      View in: PubMed
    136. Herman MG, Abrams RA, Mayer RR. Clinical use of on-line portal imaging for daily patient treatment verification. Int J Radiat Oncol Biol Phys. 1994 Mar 01; 28(4):1017-23. PMID: 8138427.
      View in: PubMed
    137. Abrams RA, Dobkin RS. The gap effect and inhibition of return: interactive effects on eye movement latencies. Exp Brain Res. 1994; 98(3):483-7. PMID: 8056068.
      View in: PubMed
    138. Abrams RA, Pratt J. Rapid aimed limb movements: differential effects of practice on component submovements. J Mot Behav. 1993 Dec; 25(4):288-98. PMID: 15064195.
      View in: PubMed
    139. Bierman PJ, Vose JM, Leichner PK, Quadri SM, Armitage JO, Klein JL, Abrams RA, Dicke KA, Vriesendorp HM. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J Clin Oncol. 1993 Apr; 11(4):698-703. PMID: 8478663.
      View in: PubMed
    140. Sitzmann JV, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg. 1993 Feb; 217(2):149-54. PMID: 8382468; PMCID: PMC1242754.
    141. Abrams RA. Recent developments in radiotherapy. Curr Opin Oncol. 1992 Dec; 4(6):1099-107. PMID: 1457524.
      View in: PubMed
    142. Merrill PT, Paige GD, Abrams RA, Jacoby RG, Clifford DB. Ocular motor abnormalities in human immunodeficiency virus infection. Ann Neurol. 1991 Aug; 30(2):130-8. PMID: 1680302.
      View in: PubMed
    143. Abrams R, Swartz CM, Vedak C. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry. 1991 Aug; 48(8):746-8. PMID: 1883258.
      View in: PubMed
    144. Abrams RA, Landgraf JZ. Differential use of distance and location information for spatial localization. Percept Psychophys. 1990 Apr; 47(4):349-59. PMID: 2345688.
      View in: PubMed
    145. Jampala VC, Taylor MA, Abrams R. The diagnostic implications of formal thought disorder in mania and schizophrenia: a reassessment. Am J Psychiatry. 1989 Apr; 146(4):459-63. PMID: 2929745.
      View in: PubMed
    146. Leechuy I, Abrams R, Kohlhaas J. ECT-induced postictal delirium and electrode placement. Am J Psychiatry. 1988 Jul; 145(7):880-1. PMID: 3381936.
      View in: PubMed
    147. Abrams RA, Wilson JF, Komorowski RA, Collins D, Toohill RJ. Esthesioneuroblastoma masquerading as extramedullary plasmacytoma. Cancer. 1987 Jul 01; 60(1):88-9. PMID: 2438030.
      View in: PubMed
    148. Abrams RA, King D, Wilson JF. Objective response of malignant carcinoid to radiation therapy. Int J Radiat Oncol Biol Phys. 1987 Jun; 13(6):869-73. PMID: 3583857.
      View in: PubMed
    149. Cox JD, Samson MK, Herskovic AM, Abrams R, Koehler M. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group. Cancer Treat Rep. 1986 Oct; 70(10):1219-20. PMID: 3019546.
      View in: PubMed
    150. Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA, et al. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54. PMID: 3020181.
      View in: PubMed
    151. Abrams RA, Hanson G, Hansen RM, Anderson T. Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia. Cancer Treat Rep. 1986 Apr; 70(4):535. PMID: 3754490.
      View in: PubMed
    152. Abrams RA, Lichter AS, Bromer RH, Minna JD, Cohen MH, Deisseroth AB. The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy. Cancer. 1985 Apr 01; 55(7):1429-35. PMID: 2983854.
      View in: PubMed
    153. Abrams RA, Johnston-Early A, Kramer C, Minna JD, Cohen MH, Deisseroth AB. Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung. Cancer Res. 1981 Jan; 41(1):35-41. PMID: 6256063.
      View in: PubMed
    Abrams's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description